At a Glance
| Bromo-DragonFLY | ALD-52 | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 300–500 µg | 100–175 µg |
| Total Duration | 11–25 hrs | 4.3–7.7 hrs |
| Routes | oral | oral |
| Effects | 66 documented | 71 documented |
Bromo-DragonFLY, a Psychedelic, and ALD-52, a Psychedelic, are frequently compared by users looking to understand their relative effects, dosage profiles, and safety considerations. Both are classified as Psychedelics, meaning they share a common pharmacological foundation. They share 50 documented effects in common, with 16 effects unique to Bromo-DragonFLY and 21 unique to ALD-52. This side-by-side comparison covers dosage, duration, subjective effects, and safety to help you make informed decisions.
| Bromo-DragonFLY | ALD-52 | |
|---|---|---|
| Class | Psychedelic | Psychedelic |
| Common Dose (oral) | 300–500 µg | 100–175 µg |
| Total Duration | 11–25 hrs | 4.3–7.7 hrs |
| Routes | oral | oral |
| Effects | 66 documented | 71 documented |
| Level | Bromo-DragonFLY | ALD-52 |
|---|---|---|
| Threshold | 75 µg | 30 µg |
| Light | 100–300 µg | 30–100 µg |
| Common | 300–500 µg | 100–175 µg |
| Strong | 500–750 µg | 175–325 µg |
| Heavy | 750 µg | 325 µg |
Bromo-DragonFLY
ALD-52
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
No dangerous interactions recorded.